HomeUBX • NASDAQ
add
Unity Biotechnology Inc
Nakaraang pagsara
$1.13
Sakop ng taon
$0.85 - $3.10
Market cap
19.45M USD
Average na Volume
190.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 4.12M | 6.21% |
Net na kita | -7.30M | -26.11% |
Net profit margin | — | — |
Kita sa bawat share | -0.43 | -26.47% |
EBITDA | -6.71M | 8.94% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 16.93M | -53.39% |
Kabuuang asset | 30.35M | -48.44% |
Kabuuang sagutin | 30.55M | -12.40% |
Kabuuang equity | -205.00K | — |
Natitirang share | 17.21M | — |
Presyo para makapag-book | -113.00 | — |
Return on assets | -50.66% | — |
Return on capital | -65.71% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -7.30M | -26.11% |
Cash mula sa mga operasyon | -6.36M | -22.65% |
Cash mula sa pag-invest | 6.78M | 194.24% |
Cash mula sa financing | — | — |
Net change in cash | 419.00K | 103.39% |
Malayang cash flow | -3.48M | -64.88% |
Tungkol
Unity Biotechnology, Inc. is a publicly traded American biotechnology company that develops drugs that target senescent cells. Wikipedia
Itinatag
2011
Headquarters
Website
Mga Empleyado
16
